Article
Treatment of left ventricular dysfunction in dilated cardiomyopathy with a myeloperoxidase inhibitor
2022-11-08
Abstract excerpt
Dilated cardiomyopathy (DCM), an incurable disease of the cardiomyocyte terminating in systolic heart failure (HFrEF), is prevalent, causes hospitalization and is associated with increased mortality. Despite evidence of immune activation in DCM, anti-inflammatory interventions so far did not prove to alter the course of this disease. Here we show that myeloperoxidase (MPO), the principal heme peroxidase expressed...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c035e46d-f626-5379-8d10-c4a1eab7cfcf
- DOI
- 10.1101/2022.11.02.22281785
